Ertapenem vs meropenem coverage
[DOCX File]PPHP Part D 1-Tier CY20
https://info.5y1.org/ertapenem-vs-meropenem-coverage_1_357c36.html
Generally, if you are taking a drug on our 2020 formulary that was covered at the beginning of the year, we will not discontinue or reduce coverage of the drug during the 2020 coverage year except when a new, less expensive generic drug becomes available, when new information about the safety or effectiveness of a drug is released, or the drug is removed from the market.
[DOC File]General Outline for Antibiotics (a good study guide)
https://info.5y1.org/ertapenem-vs-meropenem-coverage_1_a4296f.html
B. meropenem and ertapenem - same as imipenem but do not require cilastatin. C. aztrenam (a monobactam) 1. antimicrobial activity . a) only active against G- bacteria, including Pseudomonas. b) not effective against anaerobes. 2. absorption – parental administration only. 3. fate after absorption – …
[DOCX File]JHI paper Structure by 5th March first draft 2nd July 2012
https://info.5y1.org/ertapenem-vs-meropenem-coverage_1_65bbe5.html
Ertapenem shares the broad spectrum of imipenem and meropenem against Enterobacteriaceae, Gram-positive species and anaerobes, but is less active against non-fermenters (Livermore . et al. 2003) and is sometimes called a Group 1 carbapenem on this …
SOME COMMON AND IMPORTANT SURGICAL INFECTIONS
JMA Bohnen Dec 2009. Topics: some common and important surgical infections S. AUREUS INFECTIONS. Source: blood: native or prosthetic valve, metastastatic from anywhere esp line: contiguous: anywhere (eg skin to bone to joint); aspiration; exog from OR, trauma.. Pathol: Toxin: food poisoning, toxic shock; invasion: 1) abscess incl surgical site, traumatic wounds; skin incl furuncle, …
Case Notes for:
1) In low-risk patients with community-acquired intraabdominal infections, empirical coverage against Enterococcus sp. and Pseudomonas sp. is not necessary. 2) In high-risk patients and in patients with anticipated prolonged hospital stay, extended coverage against most Gm (-) aerobic/facultative anaerobic organisms is recommended.
[DOC File]Surveillance and reporting of antimicrobial resistance and ...
https://info.5y1.org/ertapenem-vs-meropenem-coverage_1_39b15d.html
(Anti-MRSA Cephalosporins) Restricted role in MRSA infection na Imipenem, meropenem, doripenem and ertapenem (Carbapenems) Very broad-spectrum reserve agents for multi-resistant and serious Gram-negative and mixed infections Use as a last resort option for multi-resistant Gram-negative infections in dogs has been reported in Australia Aztreonam ...
SOME COMMON AND IMPORTANT SURGICAL INFECTIONS
clox, pen+clox, cefaz, amox/clav, clinda, clarithro etc + close observ NEJM 2004;350:904. If not improving in 24h add Gm neg, anaerobe coverage, consider explore for Type 2. Treat type 2 infections the same . regardless of microbial etiology or tissue level: debride aggressively, amputate if nec. (Exception: TSS . below). Resusc with O2, fluids.
[DOC File]PHARMACOLOGY BASIC PRINCIPLES
https://info.5y1.org/ertapenem-vs-meropenem-coverage_1_0a60f1.html
Cough suppression vs . sedation) shows specificity. Therapeutic index: relation of dose of drug for required effect to dose that produces toxic . effect (ratio of TD50 to ED50) – clinically acceptable risk of toxicity depends on severity of disease being treated. Variation in Drug Responsiveness.
[DOC File]สาเหตุ ชนิด ปัจจัยเสี่ยงและผลที่ตามมาของภาวะสมองพิการใน ...
https://info.5y1.org/ertapenem-vs-meropenem-coverage_1_0230fa.html
The result showed the potent in vitro activity of ertapenem, meropenem and imipenem against ESBL- producing K. pneumoniae and E. coli with 100 percent susceptibility by the disc diffusion and the MIC method with the MIC90 of ESBL- producing K. pneumoniae for ertapenem, meropenem, and imipenem were 0.23, 0.09 and 0.38 µg/ml, respectively and ...
[DOC File]Drug - University of Washington
https://info.5y1.org/ertapenem-vs-meropenem-coverage_1_e4e74b.html
PD (time vs. concentration dependent killing) Time-dependent . Side effects (what, how common, monitoring) Diarrhea--common, call MD if excessive, blood in stool or abdominal cramping. Allergies Possible anaphylaxis or rash. Drug interactions Not common. Dose (renal/hepatic failure, obesity) AOM: 90mg/kg/day, div BID x 10 days
Nearby & related entries:
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.